PreprintLicence not statedChemRxiv
A dual-targeting nitrogen mustard-class I HDAC inhibitor hybrid molecule is superior to the combination of an HDAC inhibitor plus chlorambucil in glioblastoma cells
- 1Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Duesseldorf, Universitaetsstrasse 1, Duesseldorf, Germany, 40225
- 2Department of Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, Bonn, Germany, 53121
Related
- A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma
- Design, synthesis, and in vitro antiproliferative evaluation of dasatinib/HO-1 inhibitor codrugs towards glioblastoma therapy.
- Exploring gefitinib to enhance endocytosis of antibodies and nucleic acid aptamers targeting EGFR in glioblastoma
- Regioselective SN2 opening of α,β-ethylenic epoxides by RLi–BF3 combination
- Bio-based chitosan aerogel composites with multifunctional combination of thermal insulation, sound absorption, flame retardancy, and superhydrophobicity
BibTeX
@misc{biermann2026dualtargeting,
title = {{A dual-targeting nitrogen mustard-class I HDAC inhibitor hybrid molecule is superior to the combination of an HDAC inhibitor plus chlorambucil in glioblastoma cells}},
author = {Lukas Biermann and Stephan Lepper and Alexandra Hamacher and Yu-Lin Ho and Michele Bonus and Holger Gohlke and Finn K. Hansen and Matthias U. Kassack},
howpublished = {ChemRxiv},
year = {2026},
month = nov,
doi = {10.26434/chemrxiv.15003554/v3},
url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15003554/v3},
}
RIS
TY - UNPB
TI - A dual-targeting nitrogen mustard-class I HDAC inhibitor hybrid molecule is superior to the combination of an HDAC inhibitor plus chlorambucil in glioblastoma cells
AU - Lukas Biermann
AU - Stephan Lepper
AU - Alexandra Hamacher
AU - Yu-Lin Ho
AU - Michele Bonus
AU - Holger Gohlke
AU - Finn K. Hansen
AU - Matthias U. Kassack
PY - 2026
DA - 2026/11/01
PB - ChemRxiv
DO - 10.26434/chemrxiv.15003554/v3
UR - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15003554/v3
ER -